問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
許獻文
下載
2025-04-01 - 2030-06-18
Condition/Disease
Advanced hepatocellular carcinoma
Test Drug
Atezolizumab Bevacizumab Rilvegostomig (AZD2936) Tremelimumab
Participate Sites8Sites
Recruiting8Sites
2018-11-30 - 2028-12-31
Participate Sites10Sites
Not yet recruiting1Sites
Digestive System Department
2024-09-15 - 2029-12-31
Participate Sites5Sites
Recruiting5Sites
2023-12-01 - 2027-07-01
2023-01-30 - 2028-11-27
Participate Sites7Sites
Recruiting7Sites
2024-09-01 - 2027-04-30
Participate Sites4Sites
Recruiting4Sites
2023-02-01 - 2030-01-31
2023-02-01 - 2027-12-31
Participate Sites6Sites
Not yet recruiting2Sites
2023-08-01 - 2028-06-30
2021-11-01 - 2030-12-01
全部
